Michelle Dawson posts

Post published on Twitter/X on 5 Mar 2022 15:52

Twitter/X Clinical trial clinicaltrials.gov DOI work crossref Extract quoted in the post External link integrated into the post Autism terms

Open original post

5 Mar 2022

1 integrated reply by Michelle Dawson

5 Mar 2022 15:57

Note: this very small RCT started in 2010 & was completed in 2017, with results posted in 2018 https://t.co/klHoGYKZnq for anyone interested

View reply on Twitter/X

Information about the links integrated into the post

Clinical trial

Massachusetts General Hospital, Autism Speaks (2010). Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders. ClinicalTrials.gov. Massachusetts General Hospital.

More information

DOI work

Christopher J. McDougle, Robyn P. Thom, Caitlin T. Ravichandran, Michelle L. Palumbo, Laura C. Politte, Jennifer E. Mullett, Christopher J. Keary, Craig A. Erickson, et al. (2022). A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder. Neuropsychopharmacology, 47(6), 1263-1270. Springer Science and Business Media LLC.

More information

Structured cited links

2 cited resources

Clinical trial Fetched Integrated reply clinicaltrials.gov

Publication date: 2010
Identifier: NCT01302964
Authors: Massachusetts General Hospital, Autism Speaks
Source: ClinicalTrials.gov
Reference type: clinical_trial
Publisher: Massachusetts General Hospital
Metadata source: clinicaltrials.gov

Abstract

This study will determine the effectiveness of mirtazapine in reducing anxiety in children with autistic disorder, Asperger's disorder and Pervasive Developmental Disorder.

Open source Link to cited source

DOI work Fetched Post crossref

Publication date: 3 Mar 2022
Identifier: 10.1038/s41386-022-01295-4
Authors: Christopher J. McDougle, Robyn P. Thom, Caitlin T. Ravichandran, Michelle L. Palumbo, Laura C. Politte, Jennifer E. Mullett, Christopher J. Keary, Craig A. Erickson, Kimberly A. Stigler, Lauren Mathieu-Frasier, David J. Posey
Source: Neuropsychopharmacology
Details: 47(6), 1263-1270
Reference type: article
Publisher: Springer Science and Business Media LLC
Metadata source: crossref

Abstract

No abstract is available in the recovered metadata.

Study authors in this cited reference

Christopher J. McDougle (18 other cited references)
Robyn P. Thom (2 other cited references)
Caitlin T. Ravichandran (2 other cited references)
Michelle L. Palumbo (2 other cited references)
Laura C. Politte (1 other cited reference)
Jennifer E. Mullett (2 other cited references)
Christopher J. Keary (1 other cited reference)
Craig A. Erickson (13 other cited references)
Kimberly A. Stigler (2 other cited references)
Lauren Mathieu-Frasier (1 other cited reference)
David J. Posey (2 other cited references)

Open DOI Link to cited source